1. Home
  2. UVE vs ABCL Comparison

UVE vs ABCL Comparison

Compare UVE & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$29.65

Market Cap

925.9M

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.30

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
ABCL
Founded
1990
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
925.9M
1.1B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
UVE
ABCL
Price
$29.65
$4.30
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$40.00
$7.75
AVG Volume (30 Days)
210.9K
4.2M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
2.58%
N/A
EPS Growth
70.32
N/A
EPS
4.23
N/A
Revenue
$1,580,798,000.00
$35,325,000.00
Revenue This Year
$1.87
$25.45
Revenue Next Year
N/A
$10.07
P/E Ratio
$7.05
N/A
Revenue Growth
4.61
7.17
52 Week Low
$18.72
$1.89
52 Week High
$35.84
$6.52

Technical Indicators

Market Signals
Indicator
UVE
ABCL
Relative Strength Index (RSI) 37.09 61.85
Support Level $29.11 $4.08
Resistance Level $31.25 $4.66
Average True Range (ATR) 1.13 0.25
MACD -0.39 0.11
Stochastic Oscillator 8.31 70.83

Price Performance

Historical Comparison
UVE
ABCL

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: